| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.965 | 58.043 | 70.852 | 77.864 | 81.291 | 84.341 | 114.328 | 138.153 |
| Total Income - EUR | - | - | 6.965 | 58.044 | 70.854 | 80.002 | 81.945 | 84.498 | 114.329 | 138.303 |
| Total Expenses - EUR | - | - | 11.699 | 21.794 | 21.770 | 26.468 | 24.885 | 37.459 | 47.402 | 55.829 |
| Gross Profit/Loss - EUR | - | - | -4.734 | 36.251 | 49.085 | 53.534 | 57.060 | 47.039 | 66.928 | 82.474 |
| Net Profit/Loss - EUR | - | - | -4.933 | 35.671 | 48.376 | 52.981 | 56.263 | 46.272 | 65.807 | 78.411 |
| Employees | - | - | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Glicarmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 12.989 | 13.088 | 12.632 | 12.266 | 13.183 | 12.539 | 12.042 | 11.942 |
| Current Assets | - | - | 6.715 | 27.780 | 45.679 | 48.502 | 46.421 | 32.180 | 41.232 | 75.804 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.222 |
| Receivables | - | - | 3.277 | 19.960 | 15.827 | 35.312 | 36.956 | 25.686 | 24.891 | 30.350 |
| Cash | - | - | 3.438 | 7.819 | 29.852 | 13.190 | 9.465 | 6.494 | 16.342 | 44.231 |
| Shareholders Funds | - | - | -4.889 | 30.871 | 50.035 | 53.031 | 56.312 | 29.882 | 49.581 | 78.459 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 24.593 | 9.996 | 8.276 | 7.737 | 3.292 | 14.837 | 3.693 | 9.287 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Glicarmed Srl